PMID: 8962588Dec 1, 1996Paper

The cost of poor birth outcomes in employer-sponsored health plans

Medical Care
D J CholletA T Sumner

Abstract

The authors examine the cost and incidence of poor birth outcomes in employer-sponsored health insurance plans. An extensive study of national inpatient and outpatient claims data for prenatal, delivery, and postnatal care of nearly 59,000 mother-infant pairs was conducted. All maternal and infant costs incurred over a 2-year period were analyzed, and, furthermore, the longitudinal claims experience of a cohort of 20,000 mothers and infants was examined in detail. The study revealed that 25% of deliveries resulted in poor birth outcomes, which accounted for 40% of total costs over a 2-year period. Extrapolated nationwide, the net direct medical care cost of poor birth outcomes in employer plans has been estimated at approximately $5.6 billion for 1990, approximately 3% of aggregate after-tax corporate profits that year. Costs related to maternity and infant care are a major source of cost for employer-sponsored health insurance plans. Poor birth outcomes represent significantly higher cost for both the mother and infant at all stages of care-prenatal, at birth, and postnatal. To the extent that poor birth outcomes relate to maternal behavior and are preventable, their very high and protracted cost may justify substantial health...Continue Reading

References

Jan 1, 1992·American Journal of Public Health·A D McDonaldM Sloan
Mar 1, 1992·American Journal of Public Health·J L Kiely, M Susser
May 1, 1992·American Journal of Public Health·J G FeldmanM Salwen
Feb 1, 1992·American Journal of Public Health·R M SchefflerC S Phibbs
Aug 1, 1991·American Journal of Public Health·M D Peoples-ShepsA Barakat
Jan 1, 1991·American Journal of Public Health·J OlsenS F Olsen
Jan 1, 1991·General Hospital Psychiatry·L S SchwartzJ A Flaherty
Apr 1, 1991·American Journal of Public Health·L FensterS H Swan
Jan 1, 1990·American Journal of Public Health·D B Petitti, C Coleman
Feb 1, 1990·American Journal of Public Health·C J HomerE Siegel
Dec 14, 1989·The New England Journal of Medicine·M Hack, A A Fanaroff
Jan 10, 1985·The New England Journal of Medicine·M C McCormick
Jul 14, 1994·The New England Journal of Medicine·D TousoulisP Toutouzas
Feb 1, 1993·American Journal of Public Health·D A BatemanM C Heagarty

❮ Previous
Next ❯

Citations

Mar 29, 2002·Health Economics·E Kathleen AdamsRobert Merritt
Jun 21, 2006·Maternal and Child Health Journal·Scott D GrosseMichele Curtis
Nov 14, 1997·Obstetrics and Gynecology·E R MyersJ Ludmir
Mar 10, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·J HendersonS Petrou
Oct 30, 1998·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·M E OssS Birch
Nov 24, 1999·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·L S WilcoxM M Adams
Jun 19, 2013·The Journal of Pediatrics·Samantha J LainChristine L Roberts
Mar 1, 2012·Seminars in Fetal & Neonatal Medicine·Stavros Petrou, Kamran Khan
May 13, 1998·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J L Cook, C L Randall
Jul 30, 2015·BJOG : an International Journal of Obstetrics and Gynaecology·K A KhanE M Boyle
Dec 26, 2012·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Katy B KozhimannilPamela Jo Johnson
May 22, 2001·Best Practice & Research. Clinical Obstetrics & Gynaecology·S PetrouC Glazener
Apr 6, 1999·Medical Care Research and Review : MCRR·E K Adams, T L Young

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.